Stratasan, LLC, a Nashville-based healthcare data analytics software provider announced it has completed a $26 million investment round led by Fulcrum Equity Partners with participation from Frist Cressey Ventures, Blue Heron Capital, Bridge Bank and Company management.
Stratasan will use this capital to further expand its product offerings as well as invest in its sales, marketing, and customer success teams.
“We are profoundly grateful for the opportunity to partner with three operationally focused growth equity firms to begin the next chapter in our journey,” said Jason Moore, Stratasan’s co-founder and CEO. “We’ve built a customer-first culture, and our entire team is looking forward to providing increased value to our current and future customers through this new investment. As we look to the future, I want to be sure to also thank our current investors and the TNInvestCo program, as they were pivotal in helping us get to where we are today.”
Stratasan is a leading provider of analytics software and services, providing market intelligence to hospitals and healthcare systems, equipping them to make better strategic growth decisions.
Gordon Crenshaw, Principal with Blue Heron Capital continued, “We invest in companies that have a truly differentiated offering in the market, and Stratasan provides that. We look forward to working closely with the team and are excited about what the future holds.”
By serving as a hub for business development intelligence, Stratasan provides a foundation for growth in the areas of strategic planning, marketing, physician relations, and expansion.
“The business of operating and growing a healthcare organization can be difficult and complex,” said Philip Lewis, Principal at Fulcrum. “However, with Stratasan’s powerful analytics software tools, administrators and operators are able to make data-driven, fact-based decisions around how to grow their organizations and thrive in a competitive market.”
Stratasan offers access to all-payer claims data (APCD) and curates, aggregates, and supports the use of state, EMR, and Medicare data, within their software platform.
“Stratasan’s market leading solutions equip leading healthcare organizations with the intelligence they need to make informed strategic decisions and appropriately deploy resources. As a result, Stratasan enables these organizations to focus on the delivery of high-quality patient care,” said Bill Frist, MD, Partner at Frist Cressey Ventures. “The product suite offered by Stratasan is best in class; their data and analytics decisioning products are a must have for any healthcare entity looking to grow intelligently.”
In addition to the investor group, seasoned operators Ken Walters, former President of Infor, and Jim Riley, former CEO of Capario, will be joining the Stratasan board of directors. Exiting will be Jim Phillips and Steve Geringer of XMi High Growth Development Fund and Nancy Allen of Rolling Hills Capital.
“The XMi team congratulates Jason and Stratasan on a terrific transaction outcome and on their significant progress to date,” said Jim Phillips. “The Company is well positioned for future growth alongside these three value-added financial partners.”
Based in Nashville, TN, Stratasan partners with more than 1,000 hospitals from the nation’s top healthcare systems, across 40+ states, providing market intelligence that equips them to achieve efficiency and effectiveness in their strategic planning initiatives.
For more information contact: Haley Devlin – firstname.lastname@example.org